The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two ...

Jardiance (empagliflozin) is a brand-name drug that’s prescribed for type 2 diabetes and more. As with other drugs, Jardiance can cause side effects, such as vaginal yeast infections and urinary tract ...

Jardiance first gained FDA approval in 2014 as a treatment to help lower blood sugar in adults with type 2 diabetes. Now, the drug can also be used to lower the risk of cardiovascular death in ...

Jardiance (empagliflozin) is prescribed to help manage type 2 diabetes and lower the risk of complications from heart failure and chronic kidney disease. Jardiance comes as an oral tablet. This drug ...

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from EMPA-REG OUTCOME ®. This is a long-term clinical trial investigating cardiovascular (CV) ...

Ann & Robert H. Lurie Children’s Hospital of Chicago is leading a clinical trial for a potential treatment of the most prevalent liver disease in children, which currently has no effective treatment.